| Product Code: ETC6751956 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of quinolones to China saw a significant increase in concentration in 2024, with top exporting countries being Italy, Ireland, India, Belgium, and the UK. This shift towards high concentration indicates a potential market consolidation. The compound annual growth rate (CAGR) from 2020 to 2024 was a healthy 6.79%, with a notable growth rate of 6.35% from 2023 to 2024. This suggests a continued upward trajectory for quinolones imports in the Chinese market, with key players likely to further solidify their positions in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Quinolones Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Quinolones Market Revenues & Volume, 2021 & 2031F |
3.3 China Quinolones Market - Industry Life Cycle |
3.4 China Quinolones Market - Porter's Five Forces |
3.5 China Quinolones Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 China Quinolones Market Revenues & Volume Share, By Pathogen Type, 2021 & 2031F |
3.7 China Quinolones Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 China Quinolones Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 China Quinolones Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 China Quinolones Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Quinolones Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in China |
4.2.2 Growing geriatric population requiring antibiotics |
4.2.3 Rising awareness and adoption of quinolones for various infections |
4.3 Market Restraints |
4.3.1 Stringent regulatory processes for drug approvals in China |
4.3.2 Rising concerns about antibiotic resistance |
4.3.3 Competition from alternative antibiotic classes |
5 China Quinolones Market Trends |
6 China Quinolones Market, By Types |
6.1 China Quinolones Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 China Quinolones Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 China Quinolones Market Revenues & Volume, By Urinary Tract Infection, 2021- 2031F |
6.1.4 China Quinolones Market Revenues & Volume, By Intra-Abdominal Infections, 2021- 2031F |
6.1.5 China Quinolones Market Revenues & Volume, By Blood Stream Infections, 2021- 2031F |
6.1.6 China Quinolones Market Revenues & Volume, By Clostridium Difficile Infections, 2021- 2031F |
6.2 China Quinolones Market, By Pathogen Type |
6.2.1 Overview and Analysis |
6.2.2 China Quinolones Market Revenues & Volume, By Gram-Positive Pathogen, 2021- 2031F |
6.2.3 China Quinolones Market Revenues & Volume, By Gram-Negative Pathogen, 2021- 2031F |
6.3 China Quinolones Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 China Quinolones Market Revenues & Volume, By Lomefloxacin, 2021- 2031F |
6.3.3 China Quinolones Market Revenues & Volume, By Gatifloxacin, 2021- 2031F |
6.3.4 China Quinolones Market Revenues & Volume, By Norfloxacin, 2021- 2031F |
6.3.5 China Quinolones Market Revenues & Volume, By Moxifloxacin, 2021- 2031F |
6.3.6 China Quinolones Market Revenues & Volume, By Ciprofloxacin, 2021- 2031F |
6.4 China Quinolones Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 China Quinolones Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 China Quinolones Market Revenues & Volume, By Injectable, 2021- 2031F |
6.5 China Quinolones Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 China Quinolones Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 China Quinolones Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 China Quinolones Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6 China Quinolones Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 China Quinolones Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 China Quinolones Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.4 China Quinolones Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 China Quinolones Market Import-Export Trade Statistics |
7.1 China Quinolones Market Export to Major Countries |
7.2 China Quinolones Market Imports from Major Countries |
8 China Quinolones Market Key Performance Indicators |
8.1 Percentage increase in prescriptions of quinolones by healthcare providers |
8.2 Number of clinical trials conducted on new formulations of quinolones |
8.3 Average length of hospital stay for patients treated with quinolones |
8.4 Rate of adverse events reported related to quinolone usage |
8.5 Number of new entrants in the quinolones market in China |
9 China Quinolones Market - Opportunity Assessment |
9.1 China Quinolones Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 China Quinolones Market Opportunity Assessment, By Pathogen Type, 2021 & 2031F |
9.3 China Quinolones Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 China Quinolones Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 China Quinolones Market Opportunity Assessment, By End User, 2021 & 2031F |
9.6 China Quinolones Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Quinolones Market - Competitive Landscape |
10.1 China Quinolones Market Revenue Share, By Companies, 2024 |
10.2 China Quinolones Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here